TISSIUM
Manufacturing · Plastics & Polymers
$118.8Mtotal raised · 2 rounds on record
$64.8Mlatest round · Venture round · Jun 2026 · 4 mo ago
$10Mrevenue · 2025 · French register
3backers · Karista, Omnes Capital
Overview
TISSIUM is creating the future of tissue reconstruction. Learn more about our novel solutions based on our proprietary platform of biomorphic programmable polymers.
Funding and backers
Total raised
$118.8M
2 rounds on record
Latest round
$64.8M
Venture round · Jun 2026 · 4 mo ago
Team
50–99
French register · Dec 2023
Revenue
$10M
2025 · French register
Backers
3
Karista, Omnes Capital
The money's age
Fresh money
4 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 24
Raised a round Venture round $64.8M
May 5
New executive TISSIUM APPOINTS MARC QUARTULLI AS VICE PRESIDENT OF CLINICAL AFFAIRS · The Manila Times
Aug 29, 2021
Raised a round Series C $54M
2013
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2026 | $64.8M | — | mobihealthnews.com |
| Series C | Aug 2021 | $54M | — | businesswire.com |
Founders and leadersfrom filings, registers and the company's site
Frank WatkinsPrésident du conseil d’administrationcompany register
Backed byfrom the funds' portfolios and accelerator catalogs
Karista 
Omnes Capital 
Sofinnova Partners Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
CeraTattva is a specialty ceramic material company focused on non-oxide polymer derived ceramics (PDC) and its polymer-to-ceramic…
About NuCera Solutions NuCera Solutions is a global leader in the development and deployment of specialty waxes and polymers for a broad…
Finally. Affordable building blocks for the bioeconomy. Water-based chemistry for deconstructing plants into sugars and polymers.
Victrex is a world leader in PEEK and PAEK-based polymer solutions, helping customers to overcome complex design and engineering challenges.
Xampla's natural plant polymer technology is the innovative technology powering materials to change the world with plastic-free…
Smart Plastic sustainable polymer additives are transforming plastics into responsible formats that reduce litter, decrease illness, combat…
People
Frank Watkins
Président du conseil d’administration
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
TISSIUM Secures €60 Million Financing Package To Support Commercial And Clinical Activities
TISSIUM announced a €60 million financing package to support its commercial and clinical activities and platform expansion. The package combines a completed €30 million Series D2 financing with a €30 million financing facility from the European Investment
Read more
Report
TISSIUM Secures €60 Million To Support Commercial And Clinical Expansion
TISSIUM announced a €60 million financing package to support its commercial and clinical activities, pipeline development, and platform expansion. The financing package includes a completed €30 million Series D2 financing and a financing facility of up to
Read more
Report
TISSIUM Selected to the French Tech Next40 Program
Paris, France, June 15, 2026 - TISSIUM, a medical technology company pioneering biomorphic programmable polymers for tissue reconstruction, today announced its selection to the French Tech Next40 Class of 2026. Following six consecutive years as a member
Read more
Report
TISSIUM APPOINTS MARC QUARTULLI AS VICE PRESIDENT OF CLINICAL AFFAIRS
Paris, France, Cambridge, USA, May 5th, 2026 - TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, announced today it has appointed Marc Quartulli as its Vice President of Clinical Affairs.
Read more
Report
TISSIUM ANNOUNCES PUBLICATION OF FIRST-IN-HUMAN CLINICAL RESULTS OF THE COAPTIUM CONNECT SYSTEM FOR ATRAUMATIC SUTURELESS NERVE REPAIR IN JHSGO
Paris, France, Cambridge, USA, March 18, 2026 - TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, is pleased to announce the publication of its first-in-human clinical study in the Journal of Hand
Read more
Report
Report
Star Tribune
Your source for Minnesota news today. Read articles, view photos or watch videos about news in Minneapolis, St. Paul, Duluth, St. Cloud, Rochester, and beyond.
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Paris
France
HQ
18 Avenue Léon Gaumont,
10-50 est. staff
18 Avenue Léon Gaumont,, 75020 Paris France